Therapeutic Use Of Bone Morphogenetic Proteins

Patent No. EP3166628 (titled "Therapeutic Use Of Bone Morphogenetic Proteins") was filed by Cambridge Enterprise on Jul 9, 2015. The application was issued on Jul 26, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLESep 30, 2020CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3166628

CAMBRIDGE ENTERPRISE
Application Number
EP15739658A
Filing Date
Jul 9, 2015
Status
Patent Maintained As Amended
Jun 23, 2023
Publication Date
Jul 26, 2023